21048 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Ligases (6)
METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#2METHOD OF TREATING LBSL BY ENHANCING DARS2 EXPRESSION
#3ASS1 Gene Insertion For The Treatment Of Citrullinemia Type I
#4METHODS TO TREAT, PREVENT, OR REDUCE HYPERAMMONEMIA
#5THERAPEUTICAL PEPTIDOMIMETIC
#6DEGRADATION OF TOXINS IN VIVO
#7ARGINASE AND ARGININOSUCCINATE SYNTHASE FOR CANCER THERAPY
#8POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA
#9Lipid Formulations for Delivery of Messenger RNA
#10MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF
#11GENE THERAPY FOR ANGELMAN SYNDROME
#12Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases
#13SECRETED UBE3A FOR TREATMENT OF NEUROLOGICAL DISORDERS
#14BACTERIA ENGINEERED TO TREAT DISORDERS IN WHICH OXALATE IS DETRIMENTAL
#15Process of Preparing mRNA-Loaded Lipid Nanoparticles
#16METHODS OF ANTIPATHOGENIC TREATMENT
#17COMPOSITION AND METHODS FOR IMPROVING HEART FUNCTION AND TREATING HEART FAILURE
#18Improved Cell-Permeable Modified Parkin Recombinant Protein for Treatment of Neurodegenerative Diseases and Use Thereof
#19Nucleobase Editors
#20CIRCULAR RNA MOLECULE AND USE THEREOF IN TARGETED DEGRADATION OF PROTEIN OF INTEREST
#21COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES
#22TARS DERIVED FROM AKKERMANSIA MUCINIPHILA OR FRAGMENT THEREOF, AND USE THEREOF
#23USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA
#24Use of glutamine synthetase for treating hyperammonemia
#25COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS
#26METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV
#27Lipid formulations for delivery of messenger RNA
#28Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides
#29UBE3A FOR THE TREATMENT OF ANGELMAN SYNDROME
#30POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA
#31SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA
#32COMPOSITIONS AND METHODS FOR PROVIDING CHEMOPROTECTIVE EFFECTS
#33MRNA THERAPY FOR ARGININOSUCCINATE SYNTHETASE DEFICIENCY
#34USE OF GLUTAMINE SYNTHETASE FOR TREATING FATTY LIVER DISEASE
#35CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF INTERNAL TISSUE INJURY
#36PRODUCTS AND METHODS FOR INHIBITION OF EXPRESSION OF MUTANT GARS PROTEIN
#37Compositions for Treatment or Prevention of Infectious Inflammatory Diseases, or Compositions for Immune Enhancement, Comprising, Tryptophanyl-tRNA Synthetase as an Active Ingredient
#38USE OF GLUTAMINE SYNTHETASE FOR TREATING HYPERAMMONEMIA
#39Compositions and methods for treating lung inflammation
#40Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#41FUSION PROTEINS
#42Poly(phosphoesters) for delivery of nucleic acids
#43INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASES
#44Hippo pathway deficiency reverses systolic heart failure post-infarction
#45Composition comprising UNE-L domain of leucyl-tRNA synthetase as effective ingredient for augmenting muscle
#46INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
#47METHODS OF PREVENTING AND TREATING DISEASES CHARACTERIZED BY SYNAPTIC DYSFUNCTION AND NEURODEGENERATION INCLUDING ALZHEIMER'S DISEASE
#48COMPOSITIONS AND METHODS FOR TREATING NRP2-ASSOCIATED DISEASES
#49Lipid formulations for delivery of messenger RNA
#50INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARAGINYL TRNA SYNTHETASES
#51Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
#52Inhibiting the onset of gout
#53Anti-RNA virus composition comprising EPRS protein or fragment thereof
#54COMPOSITIONS AND USES THEREOF
#55Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
#56Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
#57INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARTYL-TRNA SYNTHETASES
#58CONTROL ANGIOGENESIS BY REGULATING PHOSPHORYLATION OF SERYL-tRNA SYNTHETASE (SerRS)
#59Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
#60METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
#61Methods and compounds for reducing threonyl-tRNA synthetase activity
#62Universal N-glycan binding reagent
#63Lipid formulations for delivery of messenger RNA
#64Immunogenic compositions and uses thereof
#65Compositions and methods for modulating FMR1 expression
#66Reelin rescues cognitive function
#67Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
#68TREATMENT OF AUTOPHAGY-RELATED DISORDERS
#69Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
#70Process of Preparing mRNA-Loaded Lipid Nanoparticles
#71ANTIBODIES AND METHODS FOR WNT PATHWAY-RELATED DISEASES
#72Composition for treatment or prevention of infectious inflammatory diseases, or composition for immune enhancement, comprising tryptophanyl-tRNA synthetase as an active ingredient
#73Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
#74Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
#75COMPOSITIONS AND METHODS COMPRISING GLYCYL-TRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
#76Compositions and methods relating to argininosuccinate synthetase
#77Lipid formulations for delivery of messenger RNA
#78Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#79Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
#80Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
#81THROMBOPOIETIC ACTIVITY OF TYROSYL-TRNA SYNTHETASE POLYPEPTIDES
#82Aminoacyl tRNA synthetases for modulating inflammation
#83Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#84Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#85Universal N-glycan binding reagent
#86Nanoparticles comprising aminoacyl tRNA synthetase and anticancer composition comprising same
#87METHOD FOR PREDICTING RESPONSE TO THERAPY FOR CANCER
#88Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases
#89Methods of modulating WARS2
#90COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#91MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG
#92R-SPONDIN ANTAGONISTS AND METHODS OF TREATING CANCER ASSOCIATED WITH ABERRANT ACTIVATION OF WNT SIGNALING
#93Reelin rescues cognitive function
#94Cell-penetrating bacterial E3-ubiqitin-ligases for use in immunotherapy
#95Methods for suppressing adipocyte differentiation
#96COMPOSITIONS AND METHODS FOR TREATING CHARCOT-MARIE-TOOTH DISEASES AND RELATED NEURONAL DISEASES
#97TREATMENT OF AUTOPHAGY-RELATED DISORDERS
#98PROTEIN INVOLVED IN DNA REPLICATION, AND MODULATION OF ITS ACTIVITY
#99Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#100Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
#101Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
#102Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of P38 multi-tRNA synthetase complex
#103Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#104Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#105Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
#106Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
#107Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
#108Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl tRNA synthetases
#109Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
#110Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetasis
#111Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
#112Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
#113Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
#114Methods of treating cancer of the central nervous system
#115Methods and compounds for reducing threonyl-tRNA synthetase activity
#116Methods and compounds for increasing threonyl-tRNA synthetase activity
#117PEGylated aspartyl-tRNA synthetase polypeptides
#118Aminoacyl tRNA synthetases for modulating inflammation
#119Lipid formulations for delivery of messenger RNA
#120Nutritional Compositions and Methods for Treating Cognitive Impairment
#121MRNA therapy for argininosuccinate synthetase deficiency
#122COMPOSITIONS COMPRISING MG53 AND METHODS FOR THE TREATMENT AND PREVENTION OF AIRWAY INJURY
#123Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
#124Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#125Antibodies and methods for WNT pathway-related diseases
#126Thrombopoietic activity of tyrosyl-tRNA synthetase polypeptides
#127Method for therapeutic angiogenesis
#128Compositions and methods relating to argininosucccinate synthetase
#129Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#130Methods for affecting homology-directed DNA double stranded break repair
#131Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-tRNA synthetases
#132Amino acyl tRNA synthetases for modulating inflammation
#133Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#134Substances and compositions for enhancing DNA repair and methods of use
#135Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
#136Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
#137Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#138NOVEL MODULATORS OF TRAIL SIGNALLING
#139Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#140Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
#141REGULATORY FACTOR OF FOXP3 AND REGULATORY T CELLS AND USE THEREOF
#142Aminoacyl tRNA synthetases for modulating inflammation
#143tRNA synthetase fragments
#144Methods for reducing protein levels in a cell
#145Method for therapeutic angiogenesis
#146Methods for affecting homology-directed DNA double stranded break repair
#147Combination anti-HIV vectors, targeting vectors, and methods of use
#148Antibodies that bind tyrosyl-tRNA synthetases
#149Reelin rescues congnitive function
#150Uses of GRS proteins or fragments thereof
#151AMINOACYL TRNA SYNTHETASES FOR MODULATING HEMATOPOIESIS
#152ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME
#153Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer
#154Methods of treating cancer of the central nervous system
#155Substances and compositions for enhancing DNA repair and methods of use
#156THROMBOPOIETIC ACTIVITY OF TYROSYL-TRNA SYNTHETASE POLYPEPTIDES
#157CBLB for treating endotoxin-mediated disorders
#158Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities
#159tRNA synthetase fragments
#160Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#161Compositions and methods to modulate cell membrane resealing
#162ALTERED SUMOYLATION OF LAMIN A PROTEIN ASSOCIATED WITH DILATED CARDIOMYOPATHY
#163PROPHYLACTIC AND THERAPEUTIC AGENTS AND USES THEREFOR
#164Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer
#165Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#166Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#167Use of AIM3 acting as a tumor suppressor
#168Revascularization of Ischemic Retinal Tissue and Screening Method Therefor
#169Anti-angiogenic and anti-tumor properties of vascostatin and other indogen domains
#170Use of Parp Inhibitors for Prevention and Treatment of Diabetic and Insulin Resistance Complications
#171Methods for Modulating Immune and Inflammatory Responses
#172Method Of Inducing Or Modulating Immune Response
#173Systems and methods related to degradation of uremic toxins
#174Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
#175Methods of treatment and diagnosis of patients with hepatitis c infection
#176Diagnosis of kidney damage and protection against same
#177Method and composition for regulating the activity of regulatory t cells
#178Polynucleotides encoding tRNA synthetase fragments and uses thereof
#179Kits for modulating angiogenesis
#180Multi-unit complexes and uses thereof
#181Methods for treating angiogenesis
#182Methods of modulating angiogenesis
#183Diverse multi-unit complexes including a tRNA synthetase fragment
#184Novel use of aim 3 acting as a tumor suppressor
#185tRNA synthetase fragments
#186Compositions and methods for modulating angiogenesis
#187Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#188Nanogene therapy for cell proliferation disorders
#189Method and composition for regulating activity of regulatory T cells
#190Systems and methods related to degradation of uremic toxins